BC
Biocartis
BCART.BR·EBRMechelen BEFounded 2007250 employees
Micro CapbiotechPublicOncology
Platform: Idylla Mol Dx
Market Cap
$0.1B
All Drugs
2
Clinical Trials
5
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (BCART.BR)
Loading BCART.BR stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BCA-2794 | BCA-2794 | Approved | 3 | KIF18A | PV | ||
| BCA-6126 | BCA-6126 | Phase 2/3 | 2 | MALT1 | ALS |
SEC Filings & Financial Documents
SEC filings are not available for EBR-listed companies.
Biocartis trades on EBR (BE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (7)